Pharos iBio Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 12, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	110,170	98,001	191,588	-	-	-
Market Cap Growth	4.55%	-48.85%	-	-	-	-
Enterprise Value	101,532	80,945	164,210	-	-	-
Last Close Price	8510.00	7570.00	14830.00	-	-	-
PB Ratio	9.67	5.27	6.76	-	-	-
P/TBV Ratio	10.01	5.39	6.79	-	-	-
Debt / Equity Ratio	0.02	0.01	0.01	0.02	-0.04	-0.68
Net Debt / Equity Ratio	-0.76	-0.83	-0.89	-0.83	1.47	16.44
Net Debt / EBITDA Ratio	0.81	1.32	2.67	1.47	2.88	2.41
Net Debt / FCF Ratio	1.00	1.55	3.05	1.73	2.74	2.56
Asset Turnover	-	-	-	0.01	0.00	0.02
Quick Ratio	10.97	16.25	21.15	16.06	0.56	0.86
Current Ratio	11.32	16.70	21.57	16.53	0.57	0.88
Return on Equity (ROE)	-61.86%	-44.97%	-38.50%	-1825.61%	-	-
Return on Assets (ROA)	-42.99%	-31.94%	-26.12%	-28.73%	-23.78%	-32.64%
Return on Capital Employed (ROCE)	-99.30%	-67.50%	-35.50%	-59.80%	55.20%	1120.40%
Earnings Yield	-8.92%	-10.78%	-4.62%	-	-	-
FCF Yield	-7.82%	-10.21%	-4.31%	-	-	-
Buyback Yield / Dilution	-0.13%	-6.79%	-36.26%	-53.03%	-2.65%	-1.86%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.